tiprankstipranks
IBI Investment House Ltd. (IL:IBI)
TASE:IBI
Israel Market
Want to see IL:IBI full AI Analyst Report?

Ibi Inv House (IBI) AI Stock Analysis

1 Followers

Top Page

IL:IBI

Ibi Inv House

(TASE:IBI)

Select Model
Select Model
Select Model
Outperform 78 (OpenAI - 5.2)
Rating:78Outperform
Price Target:
46,352.00
▲(56.65% Upside)
Action:Upgraded
Date:05/01/26
The score is primarily driven by strong financial performance (rapid revenue growth, solid profitability, and improving free cash flow), supported by favorable technical momentum (price above major moving averages and positive MACD). The main offsets are balance-sheet risk from the 2025 debt increase and a less compelling valuation (P/E ~24) despite a moderate dividend yield.
Positive Factors
Strong Revenue Growth
Sustained, rapid top-line expansion (noted step-change in 2025 and 42.65% revenue growth) indicates rising market penetration or product uptake. A larger revenue base improves ability to fund investments, absorb shocks, and achieve scale-driven cost efficiencies over the medium term.
Negative Factors
Meaningful 2025 Debt Increase
A material step-up in debt in 2025 raises leverage and refinancing risk, reducing financial flexibility. If market rates or funding conditions tighten, higher fixed obligations could constrain investment, dividends, or opportunistic M&A over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Sustained, rapid top-line expansion (noted step-change in 2025 and 42.65% revenue growth) indicates rising market penetration or product uptake. A larger revenue base improves ability to fund investments, absorb shocks, and achieve scale-driven cost efficiencies over the medium term.
Read all positive factors

Ibi Inv House (IBI) vs. iShares MSCI Israel ETF (EIS)

Ibi Inv House Business Overview & Revenue Model

Company Description
I.B.I Investment House Ltd. is a publicly owned holding investment firm with approximately NIS 11 billion ($2.63 billion) in assets under management. The firm provides its services to individuals and institutional clients. Through its subsidiaries...

Ibi Inv House Financial Statement Overview

Summary
Strong revenue expansion and consistently solid profitability, supported by improving operating and free cash flow into 2024–2025. Offsetting factors are the meaningful rise in debt in 2025 and some variability in net income and cash-flow consistency.
Income Statement
86
Very Positive
Balance Sheet
72
Positive
Cash Flow
78
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.47B1.04B791.55M660.61M548.65M
Gross Profit1.40B696.21M511.24M417.09M357.00M
EBITDA494.39M368.28M281.08M212.29M227.69M
Net Income174.59M178.14M156.46M90.76M139.58M
Balance Sheet
Total Assets2.17B1.85B1.27B1.08B1.13B
Cash, Cash Equivalents and Short-Term Investments604.92M519.23M453.00M246.53M547.09M
Total Debt442.27M243.90M201.26M154.42M334.90M
Total Liabilities1.03B750.27M539.07M399.48M521.39M
Stockholders Equity918.42M899.76M686.62M640.44M575.47M
Cash Flow
Free Cash Flow290.24M218.35M207.56M45.23M190.60M
Operating Cash Flow307.53M249.28M269.65M61.11M197.55M
Investing Cash Flow-100.26M-97.88M-269.38M-44.08M36.90M
Financing Cash Flow-178.80M-141.00K-37.48M-80.76M-196.36M

Ibi Inv House Technical Analysis

Technical Analysis Sentiment
Positive
Last Price29590.00
Price Trends
50DMA
38677.46
Positive
100DMA
36432.02
Positive
200DMA
30340.06
Positive
Market Momentum
MACD
1746.09
Positive
RSI
61.52
Neutral
STOCH
40.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:IBI, the sentiment is Positive. The current price of 29590 is below the 20-day moving average (MA) of 42294.50, below the 50-day MA of 38677.46, and below the 200-day MA of 30340.06, indicating a bullish trend. The MACD of 1746.09 indicates Positive momentum. The RSI at 61.52 is Neutral, neither overbought nor oversold. The STOCH value of 40.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:IBI.

Ibi Inv House Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
₪6.26B17.113.92%42.65%-8.47%
73
Outperform
₪1.05B11.346.06%540.63%18.25%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
65
Neutral
₪3.28B10.025.98%14.93%38.41%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:IBI
Ibi Inv House
44,470.00
19,889.88
80.92%
IL:FBRT
Fms
23,640.00
8,310.64
54.21%
IL:LAPD
Lapidoth Cap.
8,140.00
2,153.97
35.98%
IL:IDIN
Idi Insur
22,200.00
6,337.94
39.96%
IL:JBNK
Jerusalem
2,147.00
384.02
21.78%
IL:ATRY
Atreyu Cap
7,140.00
-83.90
-1.16%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 01, 2026